Among the newer
antihypertensive agents are the beta-blocking drugs, such as
propranolol. These agents are useful as second-step drugs to be used if
diuretic therapy alone is not effective. In mild to moderately severe
hypertension,
propranolol, in does of up to 480 mg/day in combination with a
thiazide diuretic, has been found to be effective in over 80% of patients on long-term
therapy. This degree of response is essentially similar to that noted with a combination of
reserpine and a
diuretic agent. Although some observers believe that
propranolol produces many fewer side effects than the other step 2 drugs (
reserpine and
alpha-methyldopa), there are some patients who do experience
restlessness,
insomnia, and depression.
Clonidine may be substituted for another step 2
drug, is of moderate potency, but may not be tolerated by a large number of patients because of the severe dry mouth and drowsiness that it produces.
Prazosin appears to be a suitable substitute for
hydralazine as an effective vasodialator if
thiazides plus
propranolol or
thiazides plus
reserpine or
alpha-methyldopa are not effective. In some instances, it many be an acceptable second-step
drug because of its alpha-adrenoreceptor-blocking properties. The
angiotensin II competitive inhibitors or converting
enzyme inhibitors may in the future have some place in the management of
hypertension.